Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
ACS Chemical Neuroscience|August 4, 2012
Fragile X syndrome: an update on developing treatment modalitiesAileen Healy, Roger Rush, Timothy OcainAutoimmunity|July 7, 2007
Quantitation of peripheral blood markers of rat experimental autoimmune encephalomyelitisElena Izmailova, Russell Walker, Michael Fitzgerald, et al.Thorax|March 5, 2013
Antagonism of chemokine receptor CCR8 is ineffective in a primate model of asthmaLin Wang, Tracy J Jenkins, Mingshi Dai, et al.Metabolites|June 25, 2014
Metabolic and Pharmacokinetic Differentiation of STX209 and Racemic Baclofen in HumansRaymundo Sanchez-Ponce, Li-Quan Wang, Wei Lu, et al.Biological & Pharmaceutical Bulletin|March 12, 2015
Overcoming stability challenges in the quantification of tissue nucleotides: determination of 2'-C-methylguanosine triphosphate concentration in mouse liverHassan Rashidzadeh, Sanjeev Bhadresa, Steven Spencer Good, et al.Journal of Medicinal Chemistry|May 13, 2014
Discovery of novel 2-((pyridin-3-yloxy)methyl)piperazines as α7 nicotinic acetylcholine receptor modulators for the treatment of inflammatory disordersRoger B Clark, Diana Lamppu, Lyn Libertine, et al.Autoimmunity|October 25, 2006
Mice deficient in PKC theta demonstrate impaired in vivo T cell activation and protection from T cell-mediated inflammatory diseasesKaren Anderson, Michael Fitzgerald, Michelle Dupont, et al.Arthritis and Rheumatism|December 30, 2006
Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritisElena S Izmailova, Nancy Paz, Herlen Alencar, et al.Arthritis and Rheumatism|September 30, 2006
IKKbeta inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritisLisa Schopf, Anneli Savinainen, Karen Anderson, et al.Bioorganic & Medicinal Chemistry Letters|March 31, 2007
Small molecule antagonists of the CC chemokine receptor 4 (CCR4)Douglas F Burdi, Shannon Chi, Karen Mattia, et al.Pageof 2